Utérus (sarcome)

  • Accueil
  • Utérus (sarcome)
  • CA231-0000

TITRE (EN) A Phase 1/1b First-in-human Study of BMS-986463 in Advanced Malignant Tumors
PROTOCOLE ID CA231-0000
CLINICAL TRIAL.gov ID NCT06476808
TYPE(S) DE CANCER Utérus (sarcome)
PHASE Phase I
TYPE D'ÉTUDE Clinique
INSTITUTION HOPITAL GENERAL JUIF SIR MORTIMER B.DAVIS
3755 rue de la Côte Ste. Catherine
(514) 340-8222
VILLE Montréal
INVESTIGATEUR(RICE) PRINCIPAL(E) Susie Lau
COORDONATEUR(RICE) Alessandra Figueiredo De Vasconcelos
alessandra.figueiredo.devasconcelos.ccomtl@ssss.gouv.qc.ca
514-340-8222 poste 26823
STATUT  Actif en recrutement
CRITÈRES D'ÉLIGIBILITÉ (EN)
  • Participants must have an Eastern Cooperative Oncology Group Performance Status of 0 or 1.
  • Participants must have at least 1 lesion accessible for biopsy in addition to the target lesion, from which a fresh pre treatment biopsy must be obtained.
  • Participants must have an unresectable/metastatic carcinoma.
CRITÈRES D'EXCLUSION (EN)
  • Participants must not have Leptomeningeal metastases.
  • Participants must not have concurrent malignancy (present during screening) requiring treatment or history of prior malignancy active within 2 years prior to treatment.
  • Participants must not have had any prior radiation therapy within 2 weeks prior to start of study treatment.
  • Other protocol-defined Inclusion/Exclusion criteria apply.